DelNova: Addressing complications from Botox (217)

Episode 17 • May 24, 2022 • 00:19:03
DelNova: Addressing complications from Botox (217)
Innovation4Alpha
DelNova: Addressing complications from Botox (217)

May 24 2022 | 00:19:03

/

Show Notes

DelNova, Inc. is a biopharmaceutical company focused on addressing unmet medical needs. DelNova is resolving complications arising from botulinum toxin therapies (eg. Botox®). The first product under development, ReViVox™ is based on a clinically validated drug currently approved for a different medical use and route of administration. The novel formulation will manage undesirable side effects resulting from neurotoxin injections in both medical and cosmetic applications. 

Other Episodes

Episode 8

July 09, 2021 • 00:13:50
Episode Cover

Startup Profile: Recalibrate Solutions (008)

Recalibrate Solutions (RS) is creating a stethoscope for stress health monitoring of kids. It’s a 5-minute, disposable cortisol test that helps identify kids suffering...

Listen

Episode 31

August 27, 2022 • 00:24:57
Episode Cover

AllCore360: Innovative & Effective Core Rehab & Conditioning (231)

AllCore360° exists to empower patients, athletes, seniors, and everyday people to train their core muscles for improved performance and recovery in a new, more...

Listen

Episode

September 20, 2022 • 00:20:17
Episode Cover

HIPPO Health: Clinician Founded and Owned EMR for Care Teams (236)

Hippo Health was founded by experienced emergency physicians who wanted to ease healthcare frustrations and make tele-health and excellent care coordination accessible to all.Hippo...

Listen